ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    "In-House" Controlled Oxygenated Rewarming After Initial Static Cold Storage: First Clinical Application in Marginal Donor Livers

    D. Hoyer,1 Z. Mathé,1 A. Gallinat,1 A. Canbay,2 J. Treckmann,1 U. Rauen,3 A. Paul,1 T. Minor.4

    1General, Visceral and Transplantation Surgery, University Hospital Essen, Essen, Germany; 2Gastroenterology and Hepatology, University Hospital Essen, Essen, Germany; 3Institute of Physiological Chemistry, University Hospital Essen, Essen, Germany; 4Surgical Research Division, University Hospital Bonn, Bonn, Germany.

    IntroductionControlled oxygenated rewarming of cold stored livers by machine perfusion demonstrated a strong protective effect in preclinical studies. Here we report on the first clinical…
  • 2015 American Transplant Congress

    AAV-Mediated TIMP-1 Gene Therapy Ameliorates Hepatic Ischemia/Reperfusion Injury

    S. Duarte, T. Fujii, G. Lipshutz, R. Busuttil, A. Coito.

    The Dumont-UCLA Transplant Center, Los Angeles.

    Matrix metalloproteinase-9 (MMP-9) is a key mediator of leukocyte migration across vascular barriers in hepatic ischemia/reperfusion injury (IRI). Tissue inhibitor of metalloproteinase-1 (TIMP-1) is the…
  • 2015 American Transplant Congress

    Can MitoQ Improve Renal and Mitochondrial Function Following Cold Storage and Transplantation?

    L. MacMillan-Crow,1 N. Parajuli,1 D. Borja-Cacho.

    1Pharmacology/Toxicology, Univ. of Arkansas for Medical Sciences, Little Rock, AR; 2Surgery, Univ. of Arkansas for Medical Sciences, Little Rock, AR.

    The overall goal of this study is to further evaluate the effectiveness of a potential new therapy designed to minimize damage during cold preservation, increase…
  • 2015 American Transplant Congress

    A Single Center Comparison of Various BK Viremia Elimination Protocols

    Y. Qazi, K. Lee, B. Duong, R. Dhawan, L. Shinn, L. Aguirre, C. Parke, C. Wong, S. Alexopoulos, D. Olson, M. Smogorzewski.

    Division of Transplantation, University Of Southern California. Keck Med Center, Los Angeles, CA.

    Aim BK infection remains a significant complication post kidney transplantation. Best practices in BK management have evolved over time. The purpose of the study was…
  • 2015 American Transplant Congress

    hTERT, BICD1 and Chromosome 18 Polymorphisms Affecting Telomere Length Are Associated With Kidney Transplantation Outcome

    L. Domanski,1 K. Kloda,1 K. Safranow,2 A. Drozd,3 K. Ciechanowski,1 A. Ciechanowicz.4

    1Clinical Department of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University in Szczecin, Szczecin, Poland; 2Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Szczecin, Poland; 3Department of Biochemistry and Human Nutrition, Pomeranian Medical University in Szczecin, Szczecin, Poland; 4Department of Laboratory Diagnostics and Molecular Medicine, Pomeranian Medical University in Szczecin, Szczecin, Poland.

    Telomere length (TL) has been analyzed in regard to cell senescence and ageing of animals and humans, including age-related diseases. There have been also attempts…
  • 2015 American Transplant Congress

    Incorporating Markers of Donor Organ Intrinsic Biology Into Donor Quality Evaluation

    J. Suh, K. Archer, L. Gallon, I. McConell, A. King, D. Maluf, V. Mas.

    UVA, Charlottesville, VA; Northwestern University, Chicago, IL; VCU, Richmond, VA.

    Background. We aimed to identify a reliable composite scoring system (clinical / biological) to evalute organ quality and predict outcomes post-kidney transplantation (KT).Methods. 233 deceased…
  • 2015 American Transplant Congress

    Perioperative Bacterial Colonization and Postoperative Urinary Tract Infection in Kidney Transplant Recipients

    A. Han,1 C. Choi,1 S.-I. Min,1 S.-K. Min,1 S. Kim,2 M. Park,3 J. Ha.1

    1Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea; 2Department of Surgery, Myongji Hospital, Goyang-si, Gyeonggi-do, Republic of Korea; 3Korean Organ Donation Agency, Seoul, Republic of Korea.

    Background. Urinary tract infection (UTI) is the most common infection after kidney transplantation, and one of the source of the infection is thought to be…
  • 2015 American Transplant Congress

    The Differential Effect of HLA-DQ Mismatching on Renal Allograft Survival in Zero HLA-A,B,DR Mismatched Deceased Donor Transplants

    M. Casey,1 X. Wen,1 S. Rehman,1 A. Santos,1 S. Goldstein,1 K. Andreoni,1 B. Kaplan,2 K. Womer.1

    1University of Florida, Gainesville; 2University of Kansas, Kansas City.

    The role of HLA-DQ matching in renal graft survival is not well understood and difficult to interpret in the presence of other HLA antigen mismatches.…
  • 2015 American Transplant Congress

    The Impact of Microcirculation Inflammation in Predicting Treatment Response for Late Onset Antibody Mediated Rejection

    J. Lee,1 J. Lee,1 B. Lim,2 B. Kim,3 M. Ju,1 M. Kim,1 S. Kim,1 Y. Kim,1 H. Jeong,2 K. Park,4 K. Huh.1

    1Department of Transplantation Surgery, Yonsei University Health System, Seoul, Republic of Korea; 2Department of Pathology, Yonsei University Health System, Seoul, Republic of Korea; 3Department of Internal Medicine, Yonsei University Health System, Seoul, Republic of Korea; 4Department of Surgery, CHA Bundang Medical Center, Bundang, Republic of Korea.

    BackgroundThere have been marked advances of immunosuppression. However, management of late onset antibody-mediated rejection (AMR) after 6 months is still challenging. Despite important diagnostic and…
  • 2015 American Transplant Congress

    Outcomes of Treatment of Late Antibody-Mediated Rejection in Primary Renal Transplant Recipients – A Single Center Experience

    R. Prashar, A. Patel, K. Venkat.

    Division of Nephrology and Transplant Institute, Henry Ford Hospital, Detroit, MI.

    Background: Successful reversal of early post-transplant antibody mediated rejection (AMR) is well documented, but data on the results of treatment of late AMR are lacking.…
  • « Previous Page
  • 1
  • …
  • 55
  • 56
  • 57
  • 58
  • 59
  • …
  • 170
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences